Balance Sheet
Cash Flow Statement
Amortization of GoodwillAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

INVO Fertility (IVF) Change in Accured Expenses (2016 - 2025)

Historic Change in Accured Expenses for INVO Fertility (IVF) over the last 17 years, with Q2 2025 value amounting to -$65161.0.

  • INVO Fertility's Change in Accured Expenses rose 8809.89% to -$65161.0 in Q2 2025 from the same period last year, while for Sep 2025 it was $64681.0, marking a year-over-year decrease of 9118.39%. This contributed to the annual value of $1.4 million for FY2024, which is 4606.98% up from last year.
  • Per INVO Fertility's latest filing, its Change in Accured Expenses stood at -$65161.0 for Q2 2025, which was up 8809.89% from -$934839.0 recorded in Q1 2025.
  • INVO Fertility's Change in Accured Expenses' 5-year high stood at $1.1 million during Q4 2024, with a 5-year trough of -$934839.0 in Q1 2025.
  • Its 5-year average for Change in Accured Expenses is $127439.3, with a median of $99597.5 in 2021.
  • Per our database at Business Quant, INVO Fertility's Change in Accured Expenses crashed by 127031.9% in 2021 and then surged by 101174.46% in 2022.
  • INVO Fertility's Change in Accured Expenses (Quarter) stood at -$72161.0 in 2021, then surged by 1011.74% to $657924.0 in 2022, then plummeted by 31.96% to $447676.0 in 2023, then soared by 137.82% to $1.1 million in 2024, then plummeted by 106.12% to -$65161.0 in 2025.
  • Its last three reported values are -$65161.0 in Q2 2025, -$934839.0 for Q1 2025, and $1.1 million during Q4 2024.